Literature DB >> 22381582

Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging.

Zhongzheng Jia1, Daoying Geng, Tianwen Xie, Jiaoyan Zhang, Ying Liu.   

Abstract

This study was designed to quantitatively analyse neovascular permeability in glioma by dynamic contrast-enhanced MRI (DCE-MRI). Forty-four patients with glioma were included in this study. The highest value of volume transfer constant (K(trans)) and volume of extravascular extracellular space per unit volume of tissue (V(e)) were obtained and the differences in K(trans) and V(e) between low-grade glioma (LGG) and high-grade glioma (HGG) were analyzed. The correlations between K(trans), V(e) and glioma grade were performed. Receiver operating characteristic (ROC) curve analyses were conducted. The values of K(trans) and V(e) of LGG were significantly lower than those of HGG. The correlation analysis demonstrated statistically significant relationships between K(trans) and glioma grade, between V(e) and glioma grade, and between K(trans) and V(e). The ROC curve analyses of K(trans) (0.035/min) and V(e) (0.130) for differentiating LGG from HGG were statistically significant. Thus, DCE-MRI can be used to estimate neovascular permeability and for pre-operative grading of glioma.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381582     DOI: 10.1016/j.jocn.2011.08.030

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  25 in total

1.  Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.

Authors:  Rihyeon Kim; Seung Hong Choi; Tae Jin Yun; Soon-Tae Lee; Chul-Kee Park; Tae Min Kim; Ji-Hoon Kim; Sun-Won Park; Chul-Ho Sohn; Sung-Hye Park; Il Han Kim
Journal:  Eur Radiol       Date:  2016-06-29       Impact factor: 5.315

2.  Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.

Authors:  Vera C Keil; Bogdan Pintea; Gerrit H Gielen; Susanne Greschus; Rolf Fimmers; Jürgen Gieseke; Matthias Simon; Hans H Schild; Dariusch R Hadizadeh
Journal:  J Neurooncol       Date:  2017-04-19       Impact factor: 4.130

3.  Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.

Authors:  Roh-Eul Yoo; Seung Hong Choi; Tae Min Kim; Chul-Kee Park; Sung-Hye Park; Jae-Kyung Won; Il Han Kim; Soon Tae Lee; Hye Jeong Choi; Sung-Hye You; Koung Mi Kang; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn
Journal:  Eur Radiol       Date:  2016-12-14       Impact factor: 5.315

4.  Understanding brain penetrance of anticancer drugs.

Authors:  Victor A Levin; Benjamin M Ellingson
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 12.300

5.  Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading.

Authors:  S C Jung; J A Yeom; J-H Kim; I Ryoo; S C Kim; H Shin; A L Lee; T J Yun; C-K Park; C-H Sohn; S-H Park; S H Choi
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-02       Impact factor: 3.825

6.  Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer.

Authors:  Jing Yu; Qing Xu; Dong-Ya Huang; Jia-Cheng Song; Yan Li; Lu-Lu Xu; Hai-Bin Shi
Journal:  Eur Radiol       Date:  2016-09-05       Impact factor: 5.315

7.  Prognostic Predictions for Patients with Glioblastoma after Standard Treatment: Application of Contrast Leakage Information from DSC-MRI within Nonenhancing FLAIR High-Signal-Intensity Lesions.

Authors:  S H Kim; K H Cho; S H Choi; T M Kim; C K Park; S H Park; J K Won; I H Kim; S T Lee
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-14       Impact factor: 3.825

8.  Utility of multiparametric 3-T MRI for glioma characterization.

Authors:  Bhaswati Roy; Rakesh K Gupta; Andrew A Maudsley; Rishi Awasthi; Sulaiman Sheriff; Meng Gu; Nuzhat Husain; Sudipta Mohakud; Sanjay Behari; Chandra M Pandey; Ram K S Rathore; Daniel M Spielman; Jeffry R Alger
Journal:  Neuroradiology       Date:  2013-02-02       Impact factor: 2.804

9.  Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas.

Authors:  Francesca Piludu; Simona Marzi; Andrea Pace; Veronica Villani; Alessandra Fabi; Carmine Maria Carapella; Irene Terrenato; Anna Antenucci; Antonello Vidiri
Journal:  Neuroradiology       Date:  2015-09-12       Impact factor: 2.804

10.  Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.

Authors:  Hyun Seok Choi; Ah Hyun Kim; Sung Soo Ahn; Na-young Shin; Jinna Kim; Seung-Koo Lee
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.